The Consumer Lawsuit Against Fume E-cigarette Brand for Misleading Labeling

Apr.17.2025
The Consumer Lawsuit Against Fume E-cigarette Brand for Misleading Labeling
Fume e-cigarette brand faces federal lawsuit for misleading labeling and marketing toward minors, violating federal regulations.

Key point:

Misleading Labeling: Fume Products Labeled as "5% Nicotine" are criticized for not specifying their corresponding nicotine salt potency, potentially misleading consumers.

Marketing targeted at teenagers: accused of indirectly attracting minors through social media, circumventing sales restrictions for those under 21, in violation of federal regulations.

Official website verification mechanism is weak: users only need to click "age confirmation" to make a purchase, lacking effective identity verification mechanisms, being criticized for allowing underage users to easily make purchases.

Risk of illegal seasoning products: Fume sells a large quantity of seasoning products that have not been approved by the FDA in multiple jurisdictions, constituting illegal sales.


According to a recent report from Usaherald, the manufacturer of the e-cigarette brand Fume, QR Joy Inc. based in Florida, United States, is facing a federal class-action lawsuit filed by a consumer in New York. The lawsuit accuses the company of misleading labeling and inappropriate marketing targeting minors.

 

The lawsuit was filed by plaintiff Hayley Amiel on April 11th in the Southern District Federal Court of Florida, accusing Fumee-cigarette of misleading consumers by falsely claiming on product labels to contain "5% nicotine" and covering up the true effectiveness of the product.

 

The lawsuit alleges that Fume products use nicotine salts, which have a higher absorption rate and addiction risk in the body. The lawsuit cites scientific research stating that even a 3% nicotine salt concentration is as potent as traditional cigarettes, while Fume's 5% content is even higher, potentially misleading users trying to quit smoking or looking for alternative products.

 

In addition to labeling issues, the lawsuit also accuses QR Joy Inc. of deliberately targeting youth in their marketing efforts. The plaintiffs allege that Fume's social media promotions frequently feature young adults using e-cigarettes in group settings, and they collaborate with social media influencers popular among youth to promote their products. Despite federal laws explicitly prohibiting the sale of e-cigarette products to individuals under 21, the lawsuit argues that the company is circumventing regulations through their promotional tactics.

 

In addition, the age verification mechanism of the Fume official website has been criticized for having loopholes. The plaintiff claims that users only need to click on the "age confirmation" pop-up window on the page to enter the purchase process without any further identity verification, allowing minors to easily make purchases online.

 

The lawsuit also criticized Fume's numerous flavor products, stating that these flavors are particularly appealing to young users. The U.S. Food and Drug Administration (FDA) has not approved any flavored e-cigarette products, and in federal law and multiple jurisdictions, such products are considered illegal for sale.

 

The plaintiff is seeking to represent all American consumers who have purchased the Fume e-cigarette, and is filing claims for violations of New York and other states' consumer protection laws, as well as claims for breach of warranty and unjust enrichment.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

BAT New Zealand Says Illicit Tobacco Trade Drove Nearly 29% Revenue Decline in 2025
BAT New Zealand Says Illicit Tobacco Trade Drove Nearly 29% Revenue Decline in 2025
British American Tobacco New Zealand said the illicit tobacco trade is responsible for its profit halving and revenue falling between the 2024 and 2025 financial years. Financial results filed with the Companies Office show that BAT Holdings (New Zealand) recorded 2025 revenue of NZ$180.7 million, or about US$106.95 million based on the European Central Bank’s April 27, 2026 reference rates, down from NZ$254 million, or about US$150.33 million, in 2024.
Apr.28 by 2FIRSTS.ai
RJR Vapor Loses Tax Refund Case as Texas High Court Finds VELO Pouches Taxable
RJR Vapor Loses Tax Refund Case as Texas High Court Finds VELO Pouches Taxable
The Texas Supreme Court issued a case summary on May 8, 2026, describing its decision in Hancock v. RJR Vapor Co. LLC. The dispute centered on whether RJR Vapor’s VELO oral nicotine pouches are taxable as “tobacco products” under the Texas Tax Code. Lower courts had held that the pouches were not taxable tobacco products, but the Texas Supreme Court reversed, concluding that VELO pouches are taxable because they are made of “a tobacco substitute.”
May.09 by 2FIRSTS.ai
China Tobacco International HK Warns First-Half Revenue May Fall 25%-30%, Tobacco Leaf and Duty-Free Exposure Highlight Reliance on Traditional Tobacco
China Tobacco International HK Warns First-Half Revenue May Fall 25%-30%, Tobacco Leaf and Duty-Free Exposure Highlight Reliance on Traditional Tobacco
CTIHK expects first-half 2026 revenue to fall 25%-30%, mainly due to lower tobacco leaf imports and delayed cigarette shipments to China’s domestic duty-free market. Its 2025 revenue mix—nearly 90% from tobacco leaf-related businesses and less than 1% from new tobacco products—shows continued exposure to traditional supply chains and trade variables.
Jun.18
BAT Estimates U.S. Unauthorized Vape Market at $9.4 Billion, Plans New Vuse and Velo Launches After FDA Enforcement Shift
BAT Estimates U.S. Unauthorized Vape Market at $9.4 Billion, Plans New Vuse and Velo Launches After FDA Enforcement Shift
British American Tobacco (BAT) CEO Tadeu Marroco said the U.S. unauthorized vape market is worth about £7 billion, or US$9.43 billion. Following a shift in FDA enforcement policy, BAT plans to launch flavored Vuse products in the third quarter and an updated Velo pouch in August or September.
Jun.15
Ispire Reports Fiscal Q3 2026 Revenue of $18.7 Million and Net Loss of $9.5 Million
Ispire Reports Fiscal Q3 2026 Revenue of $18.7 Million and Net Loss of $9.5 Million
Ispire Technology reported financial results on May 7, 2026, for the third quarter of fiscal 2026, covering the three months ended March 31, 2026. Revenue was $18.7 million, compared with $26.2 million in the third quarter of fiscal 2025 and $20.3 million in the prior quarter. Gross profit was $2.0 million, with gross margin of 10.7%. Net loss was $9.5 million, or $0.17 per share. The company said it held $18.0 million in cash as of March 31, 2026, up $468,000 sequentially.
May.08 by 2FIRSTS.ai
From myblu to Zone: Imperial Brands Refocuses NGP Strategy in HY26
From myblu to Zone: Imperial Brands Refocuses NGP Strategy in HY26
mperial Brands’ HY26 results point to a more selective NGP transition. The company is using cash flow from traditional tobacco to fund targeted investments in modern oral nicotine, heated tobacco and reusable vaping systems. Its decision to exit the legacy myblu vaping business in the U.S., while expanding Zone nicotine pouches. In Europe, Imperial’s NGP growth is being driven by a multi-category portfolio including blu, Pulze and Zone/Skruf.
Special Report
May.12